Intranasal delivery of therapeutic proteins for neurological diseases.
about
Microbubbles coupled to methotrexate-loaded liposomes for ultrasound-mediated delivery of methotrexate across the blood-brain barrierNoninvasive and targeted drug delivery to the brain using focused ultrasound.Intranasal "painless" human Nerve Growth Factor [corrected] slows amyloid neurodegeneration and prevents memory deficits in App X PS1 miceBrain Uptake of Neurotherapeutics after Intranasal versus Intraperitoneal Delivery in Mice.Brain transit and ameliorative effects of intranasally delivered anti-amyloid-β oligomer antibody in 5XFAD mice.The therapeutic potential of IGF-I in skeletal muscle repair.Intranasal Administration of Interleukin-1 Receptor Antagonist in a Transient Focal Cerebral Ischemia Rat Model.The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor.Targeting midkine and pleiotrophin signalling pathways in addiction and neurodegenerative disorders: recent progress and perspectives.New innovations: therapeutic opportunities for intellectual disabilities.From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF)Nasal-nanotechnology: revolution for efficient therapeutics delivery.Intranasal gene delivery for treating Parkinson's disease: overcoming the blood-brain barrier.Evidence of nose-to-brain delivery of nanoemulsions: cargoes but not vehicles.Preliminary studies for the development of intranasal nanoemulsion containing CNS agent: emphasizing the utilization of cut and weigh method.
P2860
Q30427348-2A14E947-C8DB-44C6-B803-89CF368D550CQ30439968-2339E3E1-D7FA-43A0-A118-4FA4CE973E17Q34292513-3C314A3C-71AC-4835-9C4C-6AAEF731039BQ36052412-5B0D58FD-E356-4024-BC82-FE9A5B7BE751Q37042410-A449578A-D669-49EA-8D00-866025AF4585Q37068201-70E15973-2A99-4A89-8197-62DD0EB993F1Q37685027-61D8AD85-A475-4A7A-B885-1DEB7AA69760Q37736982-0CAA0987-F06D-4A43-8115-DC9387ABA19EQ38124378-ED6F35F3-C78C-45D9-AFC1-1F61EF36C72BQ38137883-6CFA142D-9BA1-42B4-8E9C-19ED73D133A8Q38168376-C42DE9BE-DC0F-4FF7-9321-6085180C8B6DQ38217878-FCCFCB09-5F61-4AE9-8614-4C4B87C8DEA4Q38569775-8D77B94D-3ECB-4080-B048-CA41C4DAA72EQ48384614-DF813F53-C50F-481E-9A3F-FF4A9F683ED5Q50867130-E37450E5-A70B-4DE2-B1BA-1B79F5C23C04
P2860
Intranasal delivery of therapeutic proteins for neurological diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intranasal delivery of therapeutic proteins for neurological diseases.
@en
Intranasal delivery of therapeutic proteins for neurological diseases.
@nl
type
label
Intranasal delivery of therapeutic proteins for neurological diseases.
@en
Intranasal delivery of therapeutic proteins for neurological diseases.
@nl
prefLabel
Intranasal delivery of therapeutic proteins for neurological diseases.
@en
Intranasal delivery of therapeutic proteins for neurological diseases.
@nl
P2860
P1476
Intranasal delivery of therapeutic proteins for neurological diseases
@en
P2093
Francesca Malerba
Francesca Paoletti
P2860
P304
P356
10.1517/17425247.2011.588204
P407
P577
2011-05-27T00:00:00Z